Table 5 |
||||
|
Sensitivity analysis results for costs of nationwide implementation (using Composite Scenario IV as base case, 2003 USD) |
||||
|
Activities |
Base Case (Composite Scenario IV) |
Strengthening the Implementation team |
Increased Facility utilization |
Cheaper ACT |
|
|
||||
|
Implementation team |
82,818 |
290,366 |
82,818 |
82,818 |
|
Office equipments |
31,415 |
281,487 |
31,415 |
31,415 |
|
Development of IEC Materials |
35,666 |
35,666 |
35,666 |
35,666 |
|
Training |
1,721,766 |
1,721,766 |
1,721,766 |
1,721,766 |
|
Total Drug purchase |
33,089,679 |
33,089,679 |
49,634,518 |
9,245,601 |
|
Drug Handling & Distribution |
4,632,555 |
4,632,555 |
6,948,833 |
1,294,384 |
|
Communication & Publicity |
7,463,627 |
7,463,627 |
7,463,627 |
7,463,627 |
|
Other supplies |
1,214,166 |
1,214,166 |
1,214,166 |
1,214,166 |
|
Total (USD) |
48,271,692 |
48,729,312 |
67,132,809 |
21,089,443 |
|
Total (TZS) |
51,409,351,760 |
51,896,717,192 |
71,496,441,307 |
22,460,256,995 |
|
Percentage change |
+0.9% |
+39.0% |
-56.0% |
|
|
|
||||
|
Njau et al. Malaria Journal 2008 7:4 doi:10.1186/1475-2875-7-4 |
||||